Setting up a homecare service for zoledronic acid treatment of osteoporosis
See Mun Wong1, Sarah Pacey2, Opinder Sahota3
1Department of Pharmacy, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Abstract:
Increasingly, patients are able to receive parenteral medicines at home rather than in the hospital setting. We describe our approach to setting up a new intravenous zoledronic acid homecare service for patients with osteoporosis. Initial evaluation of service feasibility demonstrated a marginal cost saving of approximately 6%, when the drug is administered via homecare compared with hospital day-case unit. Rigorous risk assessment was conducted prior to service initiation. Implementation strategies are outlined. Surveys confirmed that the majority of patients were highly satisfied with the home infusion service.
Related Concept Videos
Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Preventive Healthcare Services
Setting Time of Cement
Amino acids
Mixtures of Acids
A Mixture of a Strong Acid and a Weak Acid
In a mixture of a strong acid and a weak acid, the strong acid dissociates completely and becomes a source of almost all the hydronium ions...
Polyprotic Acids


